Clinical Trial

A Clinical Study of iPSC-Derived Islet Cells for Diabetes Mellitus Therapy

Name: A Clinical Study of iPSC-Derived Islet Cells for Diabetes Mellitus Therapy — clinical trial record (NCT07464119)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

This is a single-arm, open-label clinical trial designed to assess the safety and therapeutic efficacy of iPSC-derived islet cell infusion in patients with diabetes mellitus.

Trial Details

NCT Number	NCT07464119
Lead Sponsor	Peking University First Hospital Collaborators: Hangzhou Reprogenix Bioscience, Inc
Conditions	Diabetes Mellitus
Enrollment	30 participants
Start Date	2026-03-16
Primary Completion	2028-12-31 (estimated)
Study Completion	2033-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-03-11